Both are GLP-1-based medications used for weight management, and both work. The right choice comes down to how they act and what fits your body and goals.
Semaglutide is a GLP-1 receptor agonist. It mimics the GLP-1 hormone to reduce appetite, slow gastric emptying, and support blood-sugar regulation. It is the medication that brought GLP-1 therapy into the mainstream, with a long track record behind it.
Tirzepatide is a dual agonist: it activates both the GLP-1 and the GIP receptors. Engaging two metabolic pathways at once can produce greater appetite suppression and, for many patients, stronger results than a single-receptor medication.
This is a clinical decision, not a checkout choice. Your FreedomMD provider reviews your goals, history, and how your body responds, then recommends the medication and dose that fit, and adjusts over time.
Both medications are compounded by US-licensed pharmacies and prescribed only after a licensed provider reviews your intake. They are not FDA-approved. And with FreedomMD, your member price stays locked as your dose changes.